𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells

✍ Scribed by Patrizia Stoitzner; Laura K. Green; Jae Y. Jung; Kylie M. Price; Haley Atarea; Bronwyn Kivell; Franca Ronchese

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
480 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differential presentation of tumor antig
Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells
✍ Gerhard Held; Frank Neumann; Christine Sturm; Lars Kaestner; Nina Dauth; Diederi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 311 KB

## Abstract SSX2 is a member of the family of cancer/testis antigens. The SSX2 derived peptide SSX2~103–111~ has been shown to be presented to cytotoxic T‐lymphocytes (CTL) by Major‐Histocompatibility (MHC) Class‐I complexes after endogenous processing, more precisely by the allele HLA‐A\*0201. The

Presentation of prostate tumor antigens
Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity
✍ Tjoa, Benjamin; Boynton, Alton; Kenny, Gerald; Ragde, Haakon; Misrock, S. Leslie πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 475 KB πŸ‘ 2 views

Dendritic cells (DCs) are "professional" antigen-presenting cells capable of stimulating T-cell proliferation and cytotoxicity when loaded with and presenting specific antigens, including tumor antigens. We demonstrated the stimulation of an autologous cytotoxic T-cell response elicited by DC loaded

Recognition of tumor glycans by antigen-
Recognition of tumor glycans by antigen-presenting cells
✍ Corlien A Aarnoudse; Juan J GarcΓ­a Vallejo; EirΓ­kur Saeland; Yvette van Kooyk πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 367 KB

C-type lectin receptors on antigen-presenting cells are potent antigen-uptake receptors with specificity for glycan structures. Glycosylation changes during malignant transformation create tumor-specific carbohydrate structures that interact with C-type lectins on dendritic cells. Recent findings re